Trial intelligence / Profile preview

Remimazolam vs Propofol on LV Systolic Performance

NCT05412914Phase 4Unknown

Sponsor
Konkuk University Medical Center
Start
Jan 2023
Primary completion
Jan 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in general anesthesia (2 arms), sponsored by Konkuk University Medical Center. Primary endpoint: Averaged Longitudinal Strain of the Left Ventricle at 2.5 minutes. Status: unknown.

02

Drugs

remimazolam
03

Conditions

general anesthesia

Beyond the preview

Go deeper on NCT05412914.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05412914.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call